BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24903099)

  • 1. Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.
    Pillai JA; Bonner-Jackson A; Walker E; Mourany L; Cummings JL
    Dement Geriatr Cogn Disord; 2014; 38(3-4):224-33. PubMed ID: 24903099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.
    Mez J; Cosentino S; Brickman AM; Huey ED; Manly JJ; Mayeux R
    PLoS One; 2013; 8(6):e65246. PubMed ID: 23755200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
    J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort.
    Pillai JA; Butler RS; Bonner-Jackson A; Leverenz JB
    Dement Geriatr Cogn Disord; 2016; 42(1-2):106-16. PubMed ID: 27623397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease.
    Frank B; Ally M; Tripodis Y; Puzo C; Labriola C; Hurley L; Martin B; Palmisano J; Chan L; Steinberg E; Turk K; Budson A; O'Connor M; Au R; Qiu WQ; Goldstein L; Kukull W; Kowall N; Killiany R; Stern R; Stein T; McKee A; Mez J; Alosco M
    Neurology; 2022 Jun; 98(24):e2454-e2464. PubMed ID: 35444054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias.
    Pillai JA; Bena J; Maly EF; Leverenz JB
    Alzheimers Dement; 2023 Jul; 19(7):2956-2965. PubMed ID: 36648159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    Scheltens NME; Tijms BM; Heymans MW; Rabinovici GD; Cohn-Sheehy BI; Miller BL; Kramer JH; Wolfsgruber S; Wagner M; Kornhuber J; Peters O; Scheltens P; van der Flier WM;
    J Alzheimers Dis; 2018; 65(3):1029-1039. PubMed ID: 30103316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention to the domains of Revised Hasegawa Dementia Scale and Mini-Mental State Examination in patients with Alzheimer's disease dementia.
    Honjo Y; Ide K; Nagai K; Yuri T; Nakai H; Kawasaki I; Harada S; Ogawa N
    Psychogeriatrics; 2024 May; 24(3):582-588. PubMed ID: 38403287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease.
    Smirnov DS; Galasko D; Hansen LA; Edland SD; Brewer JB; Salmon DP
    Neurobiol Aging; 2019 Mar; 75():169-177. PubMed ID: 30579145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort.
    Pavlik VN; Chan W; Darby E
    J Alzheimers Dis; 2019; 71(2):659-669. PubMed ID: 31424408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
    J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
    O'Caoimh R; Gao Y; Svendrovski A; Illario M; Iaccarino G; Yavuz BB; Kehoe PG; Molloy DW
    J Alzheimers Dis; 2019; 68(4):1499-1510. PubMed ID: 30909214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum.
    Ranasinghe KG; Hinkley LB; Beagle AJ; Mizuiri D; Dowling AF; Honma SM; Finucane MM; Scherling C; Miller BL; Nagarajan SS; Vossel KA
    Neuroimage Clin; 2014; 5():385-95. PubMed ID: 25180158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.